カテゴリー： Market Monitor Global, 世界, 医療/バイオ

抗がん剤の世界市場見通し2023年-2029年

◆英語タイトル：Anticancer Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5672）

◆商品コード：MMG23JU5672
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：62
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Anticancer Drug Market 調査レポートは次の情報を含め、グローバルにおけるの抗がん剤市場規模と予測を収録しています。・世界の抗がん剤市場：売上、2018年-2023年、2024年-2029年
・世界の抗がん剤市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の抗がん剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「分子標的薬」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

抗がん剤のグローバル主要企業は、Roche、 Celgene、 Pfizer、 Bristol-Myers Squibb、 Novartis、 AstraZeneca、 Teva Pharmaceuticals、 Bayer、 GlaxoSmithKlineなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、抗がん剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の抗がん剤市場：タイプ別、2018年-2023年、2024年-2029年
世界の抗がん剤市場：タイプ別市場シェア、2022年
・分子標的薬、細胞毒性薬、ホルモン薬、その他

世界の抗がん剤市場：用途別、2018年-2023年、2024年-2029年
世界の抗がん剤市場：用途別市場シェア、2022年
・免疫療法、標的療法、化学療法、ホルモン療法、その他

世界の抗がん剤市場：地域・国別、2018年-2023年、2024年-2029年
世界の抗がん剤市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における抗がん剤のグローバル売上、2018年-2023年
・主要企業における抗がん剤のグローバル売上シェア、2022年
・主要企業における抗がん剤のグローバル販売量、2018年-2023年
・主要企業における抗がん剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Roche、 Celgene、 Pfizer、 Bristol-Myers Squibb、 Novartis、 AstraZeneca、 Teva Pharmaceuticals、 Bayer、 GlaxoSmithKline

*************************************************************

・調査・分析レポートの概要
抗がん剤市場の定義
市場セグメント
世界の抗がん剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の抗がん剤市場規模
世界の抗がん剤市場規模：2022年 VS 2029年
世界の抗がん剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの抗がん剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の抗がん剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：分子標的薬、細胞毒性薬、ホルモン薬、その他
抗がん剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：免疫療法、標的療法、化学療法、ホルモン療法、その他
抗がん剤の用途別グローバル売上・予測

・地域別市場分析
地域別抗がん剤市場規模 2022年と2029年
地域別抗がん剤売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Roche、 Celgene、 Pfizer、 Bristol-Myers Squibb、 Novartis、 AstraZeneca、 Teva Pharmaceuticals、 Bayer、 GlaxoSmithKline
...

Anticancer Drugs are used to treat malignancies, or cancerous growths. Drug therapy may be used alone, or in combination with other treatments such as surgery or radiation therapy.
This report aims to provide a comprehensive presentation of the global market for Anticancer Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticancer Drug. This report contains market size and forecasts of Anticancer Drug in global, including the following market information:
Global Anticancer Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Anticancer Drug market was valued at US$ 98080 million in 2022 and is projected to reach US$ 151540 million by 2029, at a CAGR of 6.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Anticancer drugs are agents that demonstrate activity against malignant disease. They include alkylating agents, antimetabolites, natural products, and hormones, as well as a variety of other chemicals that do not fall within these discrete classes but are capable of preventing the replication of cancer cells and thus are used in the treatment of cancer.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anticancer Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anticancer Drug Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Anticancer Drug Market Segment Percentages, by Type, 2022 (%)
Targeted Drugs
Cytotoxic Drugs
Hormonal Drugs
Others
Global Anticancer Drug Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Anticancer Drug Market Segment Percentages, by Application, 2022 (%)
Immunotherapy
Targeted Therapy
Chemotherapy
Hormonal Therapy
Others
Global Anticancer Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Anticancer Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anticancer Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Anticancer Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Celgene
Pfizer
Bristol-Myers Squibb
Novartis
AstraZeneca
Teva Pharmaceuticals
Bayer
GlaxoSmithKline
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anticancer Drug, market overview.
Chapter 2: Global Anticancer Drug market size in revenue.
Chapter 3: Detailed analysis of Anticancer Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anticancer Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Anticancer Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anticancer Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anticancer Drug Overall Market Size
2.1 Global Anticancer Drug Market Size: 2022 VS 2029
2.2 Global Anticancer Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anticancer Drug Players in Global Market
3.2 Top Global Anticancer Drug Companies Ranked by Revenue
3.3 Global Anticancer Drug Revenue by Companies
3.4 Top 3 and Top 5 Anticancer Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Anticancer Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anticancer Drug Players in Global Market
3.6.1 List of Global Tier 1 Anticancer Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Anticancer Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Anticancer Drug Market Size Markets, 2022 & 2029
4.1.2 Targeted Drugs
4.1.3 Cytotoxic Drugs
4.1.4 Hormonal Drugs
4.1.5 Others
4.2 By Type – Global Anticancer Drug Revenue & Forecasts
4.2.1 By Type – Global Anticancer Drug Revenue, 2018-2023
4.2.2 By Type – Global Anticancer Drug Revenue, 2024-2029
4.2.3 By Type – Global Anticancer Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Anticancer Drug Market Size, 2022 & 2029
5.1.2 Immunotherapy
5.1.3 Targeted Therapy
5.1.4 Chemotherapy
5.1.5 Hormonal Therapy
5.1.6 Others
5.2 By Application – Global Anticancer Drug Revenue & Forecasts
5.2.1 By Application – Global Anticancer Drug Revenue, 2018-2023
5.2.2 By Application – Global Anticancer Drug Revenue, 2024-2029
5.2.3 By Application – Global Anticancer Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Anticancer Drug Market Size, 2022 & 2029
6.2 By Region – Global Anticancer Drug Revenue & Forecasts
6.2.1 By Region – Global Anticancer Drug Revenue, 2018-2023
6.2.2 By Region – Global Anticancer Drug Revenue, 2024-2029
6.2.3 By Region – Global Anticancer Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Anticancer Drug Revenue, 2018-2029
6.3.2 US Anticancer Drug Market Size, 2018-2029
6.3.3 Canada Anticancer Drug Market Size, 2018-2029
6.3.4 Mexico Anticancer Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Anticancer Drug Revenue, 2018-2029
6.4.2 Germany Anticancer Drug Market Size, 2018-2029
6.4.3 France Anticancer Drug Market Size, 2018-2029
6.4.4 U.K. Anticancer Drug Market Size, 2018-2029
6.4.5 Italy Anticancer Drug Market Size, 2018-2029
6.4.6 Russia Anticancer Drug Market Size, 2018-2029
6.4.7 Nordic Countries Anticancer Drug Market Size, 2018-2029
6.4.8 Benelux Anticancer Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Anticancer Drug Revenue, 2018-2029
6.5.2 China Anticancer Drug Market Size, 2018-2029
6.5.3 Japan Anticancer Drug Market Size, 2018-2029
6.5.4 South Korea Anticancer Drug Market Size, 2018-2029
6.5.5 Southeast Asia Anticancer Drug Market Size, 2018-2029
6.5.6 India Anticancer Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Anticancer Drug Revenue, 2018-2029
6.6.2 Brazil Anticancer Drug Market Size, 2018-2029
6.6.3 Argentina Anticancer Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Anticancer Drug Revenue, 2018-2029
6.7.2 Turkey Anticancer Drug Market Size, 2018-2029
6.7.3 Israel Anticancer Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Anticancer Drug Market Size, 2018-2029
6.7.5 UAE Anticancer Drug Market Size, 2018-2029
7 Anticancer Drug Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Anticancer Drug Major Product Offerings
7.1.4 Roche Anticancer Drug Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Celgene
7.2.1 Celgene Company Summary
7.2.2 Celgene Business Overview
7.2.3 Celgene Anticancer Drug Major Product Offerings
7.2.4 Celgene Anticancer Drug Revenue in Global Market (2018-2023)
7.2.5 Celgene Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Anticancer Drug Major Product Offerings
7.3.4 Pfizer Anticancer Drug Revenue in Global Market (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Anticancer Drug Major Product Offerings
7.4.4 Bristol-Myers Squibb Anticancer Drug Revenue in Global Market (2018-2023)
7.4.5 Bristol-Myers Squibb Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Anticancer Drug Major Product Offerings
7.5.4 Novartis Anticancer Drug Revenue in Global Market (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Anticancer Drug Major Product Offerings
7.6.4 AstraZeneca Anticancer Drug Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Teva Pharmaceuticals
7.7.1 Teva Pharmaceuticals Company Summary
7.7.2 Teva Pharmaceuticals Business Overview
7.7.3 Teva Pharmaceuticals Anticancer Drug Major Product Offerings
7.7.4 Teva Pharmaceuticals Anticancer Drug Revenue in Global Market (2018-2023)
7.7.5 Teva Pharmaceuticals Key News & Latest Developments
7.8 Bayer
7.8.1 Bayer Company Summary
7.8.2 Bayer Business Overview
7.8.3 Bayer Anticancer Drug Major Product Offerings
7.8.4 Bayer Anticancer Drug Revenue in Global Market (2018-2023)
7.8.5 Bayer Key News & Latest Developments
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Company Summary
7.9.2 GlaxoSmithKline Business Overview
7.9.3 GlaxoSmithKline Anticancer Drug Major Product Offerings
7.9.4 GlaxoSmithKline Anticancer Drug Revenue in Global Market (2018-2023)
7.9.5 GlaxoSmithKline Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Anticancer Drug Market Opportunities & Trends in Global Market
Table 2. Anticancer Drug Market Drivers in Global Market
Table 3. Anticancer Drug Market Restraints in Global Market
Table 4. Key Players of Anticancer Drug in Global Market
Table 5. Top Anticancer Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Anticancer Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Anticancer Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Anticancer Drug Product Type
Table 9. List of Global Tier 1 Anticancer Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anticancer Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Anticancer Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Anticancer Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Anticancer Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Anticancer Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Anticancer Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Anticancer Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Anticancer Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Anticancer Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Anticancer Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Anticancer Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Anticancer Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Anticancer Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Anticancer Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Anticancer Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Anticancer Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Anticancer Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Anticancer Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Anticancer Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Anticancer Drug Revenue, (US$, Mn), 2024-2029
Table 30. Roche Company Summary
Table 31. Roche Anticancer Drug Product Offerings
Table 32. Roche Anticancer Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Key News & Latest Developments
Table 34. Celgene Company Summary
Table 35. Celgene Anticancer Drug Product Offerings
Table 36. Celgene Anticancer Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Celgene Key News & Latest Developments
Table 38. Pfizer Company Summary
Table 39. Pfizer Anticancer Drug Product Offerings
Table 40. Pfizer Anticancer Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Pfizer Key News & Latest Developments
Table 42. Bristol-Myers Squibb Company Summary
Table 43. Bristol-Myers Squibb Anticancer Drug Product Offerings
Table 44. Bristol-Myers Squibb Anticancer Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Bristol-Myers Squibb Key News & Latest Developments
Table 46. Novartis Company Summary
Table 47. Novartis Anticancer Drug Product Offerings
Table 48. Novartis Anticancer Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Anticancer Drug Product Offerings
Table 52. AstraZeneca Anticancer Drug Revenue (US$, Mn) & (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Teva Pharmaceuticals Company Summary
Table 55. Teva Pharmaceuticals Anticancer Drug Product Offerings
Table 56. Teva Pharmaceuticals Anticancer Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Teva Pharmaceuticals Key News & Latest Developments
Table 58. Bayer Company Summary
Table 59. Bayer Anticancer Drug Product Offerings
Table 60. Bayer Anticancer Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Bayer Key News & Latest Developments
Table 62. GlaxoSmithKline Company Summary
Table 63. GlaxoSmithKline Anticancer Drug Product Offerings
Table 64. GlaxoSmithKline Anticancer Drug Revenue (US$, Mn) & (2018-2023)
Table 65. GlaxoSmithKline Key News & Latest Developments
List of Figures
Figure 1. Anticancer Drug Segment by Type in 2022
Figure 2. Anticancer Drug Segment by Application in 2022
Figure 3. Global Anticancer Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anticancer Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anticancer Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anticancer Drug Revenue in 2022
Figure 8. By Type - Global Anticancer Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Anticancer Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Anticancer Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Anticancer Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Anticancer Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Anticancer Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Anticancer Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Anticancer Drug Revenue Market Share, 2018-2029
Figure 16. US Anticancer Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Anticancer Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Anticancer Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Anticancer Drug Revenue Market Share, 2018-2029
Figure 20. Germany Anticancer Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France Anticancer Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Anticancer Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Anticancer Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Anticancer Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Anticancer Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Anticancer Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Anticancer Drug Revenue Market Share, 2018-2029
Figure 28. China Anticancer Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Anticancer Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Anticancer Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Anticancer Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India Anticancer Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Anticancer Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Anticancer Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Anticancer Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Anticancer Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Anticancer Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Anticancer Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Anticancer Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Anticancer Drug Revenue, (US$, Mn), 2018-2029
Figure 41. Roche Anticancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Celgene Anticancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Pfizer Anticancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bristol-Myers Squibb Anticancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novartis Anticancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AstraZeneca Anticancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Teva Pharmaceuticals Anticancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bayer Anticancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. GlaxoSmithKline Anticancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 抗がん剤の世界市場見通し2023年-2029年(Anticancer Drug Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

抗がん剤の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp